Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

× No keyword cloud information.

40 in total

1. Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).

Authors: Alexander E Aleshin; Ingrid U Schraufstatter; Boguslaw Stec; Laurie A Bankston; Robert C Liddington; Richard G DiScipio
Journal: J Biol Chem Date: 2012-01-20 Impact factor: 5.157

Review 2. Complement activation, regulation, and molecular basis for complement-related diseases.

Authors: Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal: EMBO J Date: 2015-10-21 Impact factor: 11.598

3. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.

Authors: D Pilz; T Vocke; J Heesemann; V Brade
Journal: Infect Immun Date: 1992-01 Impact factor: 3.441

4. Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.

Authors: R H Daniels; B D Williams; B P Morgan
Journal: Immunology Date: 1990-11 Impact factor: 7.397

5. Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3.

Authors: Marta Biedzka-Sarek; Jari Metso; Andreas Kateifides; Taru Meri; T Sakari Jokiranta; Artur Muszyński; Joanna Radziejewska-Lebrecht; Vassilis Zannis; Mikael Skurnik; Matti Jauhiainen
Journal: J Biol Chem Date: 2011-09-06 Impact factor: 5.157

6. Plasma levels of soluble membrane attack complex are elevated despite viral suppression in HIV patients with poor immune reconstitution.

Authors: T N Schein; T E Blackburn; S L Heath; S R Barnum
Journal: Clin Exp Immunol Date: 2019-09-08 Impact factor: 4.330

The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

1. Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).

Review 2. Complement activation, regulation, and molecular basis for complement-related diseases.

3. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.

4. Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.

5. Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3.

6. Plasma levels of soluble membrane attack complex are elevated despite viral suppression in HIV patients with poor immune reconstitution.

7. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

8. A case of hereditary combined deficiency of complement components C6 and C7 in man.

9. Complement inhibition by human vitronectin involves non-heparin binding domains.

10. Physicochemical characterization of human S-protein and its function in the blood coagulation system.